Soleno Therapeutics Inc (SLNO)
Working Capital Ratio
44.10%
Quarterly · Period ending:
SLNO Working Capital Ratio
Latest reported44.10%period ending
Latest reported44.10%period ending
SLNO Quarterly Working Capital Ratio (-797.55% → 44.10%)
Quarterly working capital ratio
High-resolution chart · PNG
SLNO working capital ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Working Capital Ratio |
|---|---|
| 44.1046% | |
| 52.2234% | |
| 83.6146% | |
| 89.0282% | |
| 92.1696% | |
| 83.1315% | |
| 81.9791% | |
| 84.9476% | |
| 81.5929% | |
| 88.4676% | |
| 38.8148% | |
| 37.8102% | |
| 6.9926% | |
| 31.4526% | |
| 41.3709% | |
| 47.8636% | |
| 53.2718% | |
| 40.5451% | |
| 46.6228% | |
| 53.6758% | |
| 58.2284% | |
| 64.0562% | |
| 67.5485% | |
| 69.2895% | |
| 26.0175% | |
| 42.3871% | |
| 28.3899% | |
| 40.3117% | |
| 47.8941% | |
| 52.8215% | |
| 28.8795% | |
| 34.0871% | |
| 38.1658% | |
| 41.6718% | |
| 17.6598% | |
| 26.9774% | |
| 28.4305% | |
| 37.6275% | |
| 56.9262% | |
| 33.514% | |
| 53.2907% | |
| 39.1597% | |
| -6.888% | |
| -59.1106% | |
| 89.0434% | |
| 83.9518% | |
| -76.0024% | |
| 20.6901% | |
| -1,328.9675% | |
| -797.5532% |